Bio Essence Statistics
Total Valuation
Bio Essence has a market cap or net worth of 7.83 million. The enterprise value is 10.53 million.
| Market Cap | 7.83M |
| Enterprise Value | 10.53M |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Essence has 38.01 million shares outstanding. The number of shares has increased by 11.94% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 38.01M |
| Shares Change (YoY) | +11.94% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 90.49% |
| Owned by Institutions (%) | n/a |
| Float | 3.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.17 |
| PB Ratio | -2.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.55 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.05 |
| EV / Sales | 32.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -213.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.89% |
| Return on Invested Capital (ROIC) | -42.08% |
| Return on Capital Employed (ROCE) | 18.22% |
| Revenue Per Employee | 161,970 |
| Profits Per Employee | -654,398 |
| Employee Count | 2 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.77% in the last 52 weeks. The beta is 14.51, so Bio Essence's price volatility has been higher than the market average.
| Beta (5Y) | 14.51 |
| 52-Week Price Change | -20.77% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 32.21 |
| Average Volume (20 Days) | 230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.63 |
Income Statement
In the last 12 months, Bio Essence had revenue of 323,940 and -1.31 million in losses. Loss per share was -0.03.
| Revenue | 323,940 |
| Gross Profit | 217,077 |
| Operating Income | -459,438 |
| Pretax Income | -1.56M |
| Net Income | -1.31M |
| EBITDA | -458,292 |
| EBIT | -459,438 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 1,371 in cash and 2.70 million in debt, giving a net cash position of -2.70 million or -0.07 per share.
| Cash & Cash Equivalents | 1,371 |
| Total Debt | 2.70M |
| Net Cash | -2.70M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -2.97M |
| Book Value Per Share | -0.08 |
| Working Capital | -2.52M |
Cash Flow
| Operating Cash Flow | 623,865 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 67.01% |
| Operating Margin | -141.83% |
| Pretax Margin | -483.09% |
| Profit Margin | n/a |
| EBITDA Margin | -141.47% |
| EBIT Margin | -141.83% |
| FCF Margin | n/a |
Dividends & Yields
Bio Essence does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.94% |
| Shareholder Yield | -11.94% |
| Earnings Yield | -16.72% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bio Essence has an Altman Z-Score of -57.73. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -57.73 |
| Piotroski F-Score | n/a |